JAMA · 17 Nov 2026
Toward a Healthier Future Through Obesity Prevention and Care
Anne R. Cappola, Derek C. Angus, Rexford S. Ahima, Louis J. Aronne, Kirsten Bibbins-Domingo, Lindsay Dawson, Robert F. Kushner, Mary M. McDermott, Timothy S. Anderson, Jamy D. Ard, David E. Arterburn, Rachel L. Batterham, Kim Boyd, Jason Brett, Francesca Celletti, Rachel Cox, Deidra C. Crews, Julie M. Donohue, Gregory J. Esper, Gary D. Foster, Beth Frates, W. Timothy Garvey, Kimberly A. Gudzune, Jens Juul Holst, Jeffrey Huebner, John M. Jakicic, Linong Ji, Lee M. Kaplan, Dhruv S. Kazi, Samuel Klein, Lotte Bjerre Knudsen, Rekha B. Kumar, David S. Ludwig, T. Joseph Mattingly, Michelle McRae, Purnima Menon, Rhonda E. Monroe, John Magaña Morton, Dariush Mozaffarian, Joseph F. Nadglowski, Chiadi E. Ndumele, Marion Nestle, Alexis Ogdie, Francisco J. Pasquel, Jennifer L. Pomeranz, Nicolaas P. Pronk, Johanna Ralston, Joseph S. Ross, Naveed Sattar, Hilary K. Seligman, B. Gabriel Smolarz, Fatima Cody Stanfordh-index 41, Shannon N. Zenk, JAMA Summit on Obesity, Hannah Park, Wendy C. Whitehead
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- Crossref1
- OpenCitations0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Importance Obesity is one of the most difficult challenges of the modern era, affecting more than 1 billion people worldwide. Nearly half of US adults and 1 in 5 US children meet the medical definition of having obesity, with major consequences for cardiometabolic, kidney, hepatic, pulmonary, musculoskeletal, reproductive, oncologic, and mental health. Obesity also carries social and economic harms through stigma, discrimination, and bias. Observations Drivers of the obesity epidemic include changes in food production and consumption accompanied by social, economic, and technological shifts that reduce food preparation, disrupt sleep, and decrease physical activity. The burden of these changes is not equally distributed, with higher obesity prevalence among socioeconomically disadvantaged populations. Current prevention measures include nutrition standards, food and menu labeling, school meal policies, sugar-sweetened beverage taxes, community-based lifestyle programs, and public assistance efforts. The impact of these approaches has been inadequate. Contemporary clinical management recognizes obesity as a chronic disease characterized by genetic, biological, and behavioral susceptibilities. Access, affordability, tolerability, and the chronicity of use remain major challenges for all available obesity management strategies, including new glucagon-like peptide-1 receptor agonist therapies. Potential solutions require a coordinated, multisector response and include efforts to prevent obesity at the societal level, improve care of individuals with obesity, and strengthen research and innovation. Priority areas include improving the food and physical activity environment; strengthening communication and education; strengthening childhood obesity prevention; addressing health inequities; reducing stigma and bias; modernizing obesity care delivery; expanding access to lifestyle, healthy food, medication, and surgical interventions; and supporting long-term treatment adherence and maintenance. Proposed actions include new government policies on food production, labeling, marketing, and school nutrition; modernization of drug evaluation; payment reform to support comprehensive obesity treatment; development of multidisciplinary care models; incentives to promote cross-sector partnerships; and research to advance personalized prevention and treatment strategies. Conclusions and Relevance The emergence of effective obesity management medications offers a significant opportunity to curb the prevalence of obesity. However, no single intervention will be enough. Sustained improvement will require addressing the underlying structural and environmental drivers of obesity, along with person-centered, multilevel strategies that simultaneously improve prevention, reduce stigma, and expand equitable access to evidence-based treatment. Coordinated action across government, health care systems, clinicians, payers, industry, schools, communities, and researchers will be essential to achieving long-term improvement.
What the data shows
- Crossref counts 1 citations, the most of the databases. The others count 0.
- Fatima Cody Stanford has the highest h-index among the authors (41).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (42)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 22 more references
A free account opens the rest of the citing papers and references on every paper’s page.